NYSE

Baxter International Inc. (BAX)

309 Thanks from members

Baxter International (BAX) exhibits a cautious yet recovering market sentiment, balancing upward revisions in 2026 sales guidance and operational cost recovery against persistent balance sheet leverage, tariff headwinds, and ongoing product recall risks.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →